Novo CEO pressed by Senate to chop costs of being overweight, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the business would look at new talks with insurers concerning the checklist selling prices of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. https://daves-hot-chicken-nutriti49493.alltdesign.com/an-unbiased-view-of-healthcare-news-50327855